Results of a phase I–II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer-Reference-Cited by-同舟云学术

Results of a phase I–II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer

Published:2016-12-27 Issue:3 Volume:6 Page:e1274479
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Formenti Silvia C.¹,Golden Encouse B.¹,Goldberg Judith D.²,Li Xiaochun²,Taff Jessica³,Fenton-Kerimian Maria B.¹,Chandrasekhar Sharanya¹,Demaria Sandra¹,Novik Yelena³^ORCID

Affiliation:

1. Department of Radiation Oncology, Weill Cornell Medicine, New York, NY, USA

2. Departments of Population Health and Environmental Medicine, New York University School of Medicine, New York, NY, USA

3. Department of Medicine, New York University School of Medicine, New York, NY, USA

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1274479

Reference38 articles.

1. Chemotherapy and radiotherapy: Cryptic anticancer vaccines

2. Calreticulin exposure dictates the immunogenicity of cancer cell death

3. Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

4. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

5. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A MCL-1-targeted photosensitizer to combat triple-negative breast cancer with enhanced photodynamic efficacy, sensitization to ROS-induced damage, and immune response;Journal of Inorganic Biochemistry;2022-12

2. Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial;Clinical Cancer Research;2020-11-04

3. Radiotherapy induces responses of lung cancer to CTLA-4 blockade;Nature Medicine;2018-11-05

4. Update Breast Cancer 2018 (Part 3) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer;Geburtshilfe und Frauenheilkunde;2018-11

5. Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers;Seminars in Cancer Biology;2018-10